The Nigerian Minister of State for Health, Gabriel Aduku, has told a health summit in the country's northern state of Kaduna that about 110 million people have malaria with more than 800.0 billion naira ($6.71 billion) being spent on treatment. This figure seems somewhat high to the Marketletter, given that the country's total planned health care spending for 2008 is only $20.0 billion. Mr Aduku added that most malaria-related deaths occur in northern parts of Nigeria, accounting for over a third of infant deaths (35%), the All Africa news agency reported.
According to the World Health Organization, which published an in-depth study of the disease in Nigeria in 2005, the West African country's population is about 132 million, which would indicate a disease prevalence of over 80%. The Geneva, Switzerland-based agency also noted that "there is high resistance of the [malaria] parasite to the first and second line anti-malaria drug."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze